Cargando…

Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach

A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success...

Descripción completa

Detalles Bibliográficos
Autores principales: Karthika, Chenmala, Najda, Agnieszka, Klepacka, Joanna, Zehravi, Mehrukh, Akter, Rokeya, Akhtar, Muhammad Furqan, Saleem, Ammara, Al-Shaeri, Majed, Mondal, Banani, Ashraf, Ghulam Md., Tagde, Priti, Ramproshad, Sarker, Ahmad, Zubair, Khan, Farhat S., Rahman, Md. Habibur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320031/
https://www.ncbi.nlm.nih.gov/pubmed/35889532
http://dx.doi.org/10.3390/molecules27144663
_version_ 1784755694133575680
author Karthika, Chenmala
Najda, Agnieszka
Klepacka, Joanna
Zehravi, Mehrukh
Akter, Rokeya
Akhtar, Muhammad Furqan
Saleem, Ammara
Al-Shaeri, Majed
Mondal, Banani
Ashraf, Ghulam Md.
Tagde, Priti
Ramproshad, Sarker
Ahmad, Zubair
Khan, Farhat S.
Rahman, Md. Habibur
author_facet Karthika, Chenmala
Najda, Agnieszka
Klepacka, Joanna
Zehravi, Mehrukh
Akter, Rokeya
Akhtar, Muhammad Furqan
Saleem, Ammara
Al-Shaeri, Majed
Mondal, Banani
Ashraf, Ghulam Md.
Tagde, Priti
Ramproshad, Sarker
Ahmad, Zubair
Khan, Farhat S.
Rahman, Md. Habibur
author_sort Karthika, Chenmala
collection PubMed
description A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success rate of BT is not very high. This is the central issue faced during drug development and clinical trials with almost all types of neurodegenerative disorders. In the first part of this review, we focus on the concept of brain tumors, their barriers, and the types of delivery possible to target the brain cells. Although various treatment methods are available, they all have side effects or toxic effects. Hence, in the second part, a correlation was made between the use of resveratrol, a potent antioxidant, and its advantages for brain diseases. The relationship between brain disease and the blood–brain barrier, multi-drug resistance, and the use of nanomedicine for treating brain disorders is also mentioned. In short, a hypothetical concept is given with a background investigation into the use of combination therapy with resveratrol as an active ingredient, the possible drug delivery, and its formulation-based approach.
format Online
Article
Text
id pubmed-9320031
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93200312022-07-27 Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach Karthika, Chenmala Najda, Agnieszka Klepacka, Joanna Zehravi, Mehrukh Akter, Rokeya Akhtar, Muhammad Furqan Saleem, Ammara Al-Shaeri, Majed Mondal, Banani Ashraf, Ghulam Md. Tagde, Priti Ramproshad, Sarker Ahmad, Zubair Khan, Farhat S. Rahman, Md. Habibur Molecules Review A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success rate of BT is not very high. This is the central issue faced during drug development and clinical trials with almost all types of neurodegenerative disorders. In the first part of this review, we focus on the concept of brain tumors, their barriers, and the types of delivery possible to target the brain cells. Although various treatment methods are available, they all have side effects or toxic effects. Hence, in the second part, a correlation was made between the use of resveratrol, a potent antioxidant, and its advantages for brain diseases. The relationship between brain disease and the blood–brain barrier, multi-drug resistance, and the use of nanomedicine for treating brain disorders is also mentioned. In short, a hypothetical concept is given with a background investigation into the use of combination therapy with resveratrol as an active ingredient, the possible drug delivery, and its formulation-based approach. MDPI 2022-07-21 /pmc/articles/PMC9320031/ /pubmed/35889532 http://dx.doi.org/10.3390/molecules27144663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Karthika, Chenmala
Najda, Agnieszka
Klepacka, Joanna
Zehravi, Mehrukh
Akter, Rokeya
Akhtar, Muhammad Furqan
Saleem, Ammara
Al-Shaeri, Majed
Mondal, Banani
Ashraf, Ghulam Md.
Tagde, Priti
Ramproshad, Sarker
Ahmad, Zubair
Khan, Farhat S.
Rahman, Md. Habibur
Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
title Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
title_full Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
title_fullStr Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
title_full_unstemmed Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
title_short Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach
title_sort involvement of resveratrol against brain cancer: a combination strategy with a pharmaceutical approach
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320031/
https://www.ncbi.nlm.nih.gov/pubmed/35889532
http://dx.doi.org/10.3390/molecules27144663
work_keys_str_mv AT karthikachenmala involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT najdaagnieszka involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT klepackajoanna involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT zehravimehrukh involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT akterrokeya involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT akhtarmuhammadfurqan involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT saleemammara involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT alshaerimajed involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT mondalbanani involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT ashrafghulammd involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT tagdepriti involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT ramproshadsarker involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT ahmadzubair involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT khanfarhats involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach
AT rahmanmdhabibur involvementofresveratrolagainstbraincanceracombinationstrategywithapharmaceuticalapproach